For example, obesity-induced hyperleptinemia and increases in insulin/IGF-1 levels, as observed in the present study and in other models, can lead to activation of phosphoinositide 3-kinase and mammalian target of rapamycin (mTOR) signaling and promote primary tumor growth [92]. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.